Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients

Daan Jan Willem Rauwerdink, Olivier van Not, Melissa de Meza, Remco van Doorn, Jos van der Hage, A J M van den Eertwegh, John B Haanen, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christiaan U Blank, Marye J Boers-Sonderen, Jan Willem B de Groot, Geke A P Hospers, Djura Piersma, Rozemarijn S van Rijn, A M Stevense-den Boer, Astrid A M van der Veldt, Gerard Vreugdenhil, Michel W J M Wouters, Karijn P M SuijkerbuijkEllen Kapiteijn*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science